Largest Shareholder Lee Kwon-seon Increases Stake to 37.13%, Strengthening Control via Open Market Purchases and Affiliate Acquisition


  • As of the reporting date, the largest shareholder Lee Kwon-seon and his specially related persons increased their total shares from 3,327,804 to 3,466,938, raising the holding ratio from 35.63% to 37.13%.
  • Lee personally acquired 29,656 shares through 12 open market purchases between March and May 2026. Special relation Ahn Seong-jun acquired 105,478 shares via an equity swap due to affiliate inclusion. Lee's children Lee Ji-min and Lee Seung-yoon also made small open market purchases.
  • During the period, the total number of outstanding voting shares decreased from 8,375,748 to 8,300,792, a reduction of 74,956 shares, which could positively impact per-share value. Lee's voting rights ratio increased from 39.73% to 41.77%.
  • Funds for acquisition came from Lee's earned income of 210 million won, children's gift funds, and Ahn's equity swap. No convertible bonds or stock subscription rights are involved.
  • [AI Summary]The largest shareholder Lee Kwon-seon boosted his stake to 37.13% through open market purchases and an affiliate's share acquisition, raising voting rights to 41.77%. The decrease in total outstanding shares benefits existing shareholders but may reduce liquidity. No new financing or dilution; management control is strengthened.

KOSDAQ Filing Information


  • Report on Large Shareholding (General)
  • Company: Cell Bio Human Tech (318160)
  • Submission: Kwon-seon Lee

  • Shares: 9,337,513
  • Price: 5,660 KRW
  • Market Cap: 52.9 B KRW